There are 2137 resources available
415P - Prognostic effect of postoperative serum carcinoembryonic antigen (CEA) combined with T4 versus T3 tumors in patients with high-risk stage 2 colon cancer: ACHIEVE-2 phase III randomized clinical trial
Presenter: Akio Shiomi
Session: E-Poster Display
Resources:
Abstract
416P - A novel prognostic tool based on lymphocyte ratios in patients with stage III colon cancer
Presenter: Debora Basile
Session: E-Poster Display
Resources:
Abstract
417P - Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer
Presenter: Yitak Kim
Session: E-Poster Display
Resources:
Abstract
418P - Analysis of the efficacy of cytokine-induced killer cell therapy in adjuvant treatment of colorectal cancer
Presenter: Rui Guo
Session: E-Poster Display
Resources:
Abstract
419P - Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay
Presenter: Aparna Parikh
Session: E-Poster Display
Resources:
Abstract
420P - Minimal residual disease detection and tracking tumour evolution using ctDNA in stage I-III colorectal cancer patients
Presenter: Tenna Henriksen
Session: E-Poster Display
Resources:
Abstract
421P - Upfront chemotherapy vs. surgery for very low lying locally advanced rectal cancer without preoperative chemoradiation: The NAIR phase II/III trial
Presenter: Yuichiro Tsukada
Session: E-Poster Display
Resources:
Abstract
422P - Age and pathological complete response after neoadjuvant chemoradiation (CRT) with or without oxaliplatin in locally advanced rectal cancer (LARC): Individual patient data (IPD) meta-analysis of three randomised trials (RTs)
Presenter: Elisa Fontana
Session: E-Poster Display
Resources:
Abstract
423P - Gut microbiome predicts a response after preoperative chemoradiation in rectal cancer patients
Presenter: Bum-sup Jang
Session: E-Poster Display
Resources:
Abstract
424P - Could total neoadjuvant therapy (TNT) become a new standard in locally advanced rectal cancer (LARC)? A systematic review and meta-analysis (MA) of TNT vs. standard chemoradiotherapy (CRT)
Presenter: Maria Carmen Riesco Martínez
Session: E-Poster Display
Resources:
Abstract